ask="N/A"
ask_size="N/A"
average_daily_volume="376468"
bid="N/A"
bid_size="N/A"
book_value="0.44"
change="N/A"
change_from_200_day_moving_average="0.44"
change_from_50_day_moving_average="0.41"
change_from_52_week_high="-0.67"
change_From_52_week_low="1.55"
change_in_percent="N/A"
close="2.37"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.10"
ebitda="-24.72M"
eps_estimate_current_year="-1.13"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-0.99"
ex_dividend_date="N/A"
float_shares="21827000"
high="N/A"
high_52_weeks="3.04"
last_trade_date="2/13/2017"
last_trade_price="2.37"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="0.82"
market_capitalization="55.57M"
moving_average_200_day="1.93"
moving_average_50_day="1.96"
name="CymaBay Therapeutics Inc."
notes="N/A"
one_year_target_price="5.67"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+22.97%"
percent_change_from_50_day_moving_average="+20.67%"
percent_change_from_52_week_high="-22.04%"
percent_change_from_52_week_low="+188.99%"
previous_close="2.37"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.44"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="23447000"
short_ratio="0.45"
stock_exchange="NCM"
symbol="CBAY"
volume="0"
weeks_range_52="0.82 - 3.04"
